View ValuationFinolex Industries 将来の成長Future 基準チェック /06Finolex Industries利益と収益がそれぞれ年間5.6%と10.1%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に10.2% 5.7%なると予測されています。主要情報5.6%収益成長率5.72%EPS成長率Chemicals 収益成長18.3%収益成長率10.1%将来の株主資本利益率10.17%アナリストカバレッジGood最終更新日15 Jun 2026今後の成長に関する最新情報Price Target Changed • Feb 14Price target decreased by 8.2% to ₹206Down from ₹224, the current price target is an average from 15 analysts. New target price is 8.6% above last closing price of ₹189. Stock is down 0.5% over the past year. The company is forecast to post earnings per share of ₹7.94 for next year compared to ₹12.94 last year.Price Target Changed • Feb 12Price target decreased by 12% to ₹268Down from ₹304, the current price target is an average from 15 analysts. New target price is 38% above last closing price of ₹195. Stock is down 11% over the past year. The company is forecast to post earnings per share of ₹12.40 for next year compared to ₹7.66 last year.Price Target Changed • Jul 30Price target increased by 9.4% to ₹310Up from ₹283, the current price target is an average from 16 analysts. New target price is approximately in line with last closing price of ₹322. Stock is up 63% over the past year. The company is forecast to post earnings per share of ₹14.67 for next year compared to ₹7.66 last year.Price Target Changed • May 15Price target increased by 10% to ₹268Up from ₹243, the current price target is an average from 15 analysts. New target price is 12% below last closing price of ₹305. Stock is up 62% over the past year. The company is forecast to post earnings per share of ₹11.74 for next year compared to ₹7.66 last year.Price Target Changed • Jan 24Price target increased by 7.9% to ₹243Up from ₹225, the current price target is an average from 14 analysts. New target price is 5.8% above last closing price of ₹230. Stock is up 38% over the past year. The company is forecast to post earnings per share of ₹6.98 for next year compared to ₹4.05 last year.Price Target Changed • May 30Price target increased by 8.3% to ₹209Up from ₹193, the current price target is an average from 12 analysts. New target price is 20% above last closing price of ₹175. Stock is up 11% over the past year. The company is forecast to post earnings per share of ₹8.87 for next year compared to ₹4.04 last year.すべての更新を表示Recent updatesReported Earnings • May 27Full year 2026 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2026 results: EPS: ₹9.69 (down from ₹12.94 in FY 2025). Revenue: ₹43.2b (up 4.4% from FY 2025). Net income: ₹5.99b (down 25% from FY 2025). Profit margin: 14% (down from 19% in FY 2025). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 1.7%. Earnings per share (EPS) exceeded analyst estimates by 15%. Revenue is forecast to grow 7.0% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.お知らせ • May 27Finolex Industries Limited Recommends Special Dividend for the Year Ended March 31, 2026Finolex Industries Limited announced that the Board of Directors of the Company held its meeting on 26 May 2026. Company Recommended a special dividend of INR 0.75 (37.50%) per equity share of INR 2/- each, aggregating to INR 2.75 (137.50%) per equity share of INR 2/- each for the year ended March 31, 2026, subject to deduction of tax, as applicable and approval of Members at the ensuing 45th Annual General Meeting; (The Company will inform the date of the Forty-Fifth (45th) Annual General Meeting and the dividend payment date in due course).お知らせ • May 26Finolex Industries Limited Recommends Final Dividend for the Year Ended March 31, 2026Finolex Industries Limited announced that the Board of Directors of the Company held its meeting on 26 May 2026. Company Recommended a final dividend of INR 2 (100%) per equity share of INR 2/- each aggregating to INR 2.75 (137.50%) per equity share of INR 2/- each for the year ended March 31, 2026, subject to deduction of tax, as applicable and approval of Members at the ensuing 45th Annual General Meeting; (The Company will inform the date of the Forty-Fifth (45th) Annual General Meeting and the dividend payment date in due course.).お知らせ • May 19Finolex Industries Limited to Report Q4, 2026 Results on May 26, 2026Finolex Industries Limited announced that they will report Q4, 2026 results on May 26, 2026Price Target Changed • Feb 14Price target decreased by 8.2% to ₹206Down from ₹224, the current price target is an average from 15 analysts. New target price is 8.6% above last closing price of ₹189. Stock is down 0.5% over the past year. The company is forecast to post earnings per share of ₹7.94 for next year compared to ₹12.94 last year.Reported Earnings • Feb 01Third quarter 2026 earnings released: EPS: ₹1.88 (vs ₹1.52 in 3Q 2025)Third quarter 2026 results: EPS: ₹1.88 (up from ₹1.52 in 3Q 2025). Revenue: ₹9.50b (down 5.1% from 3Q 2025). Net income: ₹1.16b (up 24% from 3Q 2025). Profit margin: 12% (up from 9.4% in 3Q 2025). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.お知らせ • Jan 27Finolex Industries Limited to Report Q3, 2026 Results on Jan 31, 2026Finolex Industries Limited announced that they will report Q3, 2026 results at 4:00 PM, Indian Standard Time on Jan 31, 2026Reported Earnings • Nov 08Second quarter 2026 earnings released: EPS: ₹2.00 (vs ₹0.66 in 2Q 2025)Second quarter 2026 results: EPS: ₹2.00 (up from ₹0.66 in 2Q 2025). Revenue: ₹9.16b (up 11% from 2Q 2025). Net income: ₹1.24b (up 204% from 2Q 2025). Profit margin: 14% (up from 4.9% in 2Q 2025). Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 7% per year.お知らせ • Oct 28Finolex Industries Limited to Report Q2, 2026 Results on Nov 07, 2025Finolex Industries Limited announced that they will report Q2, 2026 results on Nov 07, 2025お知らせ • Sep 15+ 1 more updateFinolex Industries Limited Approves Appointment of Udipt Agarwal as Managing DirectorFinolex Industries Limited at its AGM held on September 12, 2025, approved the appointment of Mr. Udipt Agarwal as a Managing Director of the Company.Declared Dividend • Aug 22Dividend of ₹3.60 announcedShareholders will receive a dividend of ₹3.60. Ex-date: 4th September 2025 Payment date: 12th October 2025 Dividend yield will be 1.7%, which is higher than the industry average of 0.8%. Sustainability & Growth Dividend is well covered by both earnings (15% earnings payout ratio) and cash flows (46% cash payout ratio). The dividend has increased by an average of 3.6% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 79% over the next 3 years, which should provide support to the dividend and adequate earnings cover.お知らせ • Aug 04Finolex Industries Limited, Annual General Meeting, Sep 12, 2025Finolex Industries Limited, Annual General Meeting, Sep 12, 2025.New Risk • Aug 03New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 9.8% Last year net profit margin: 20% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (9.8% net profit margin).Reported Earnings • Aug 03First quarter 2026 earnings released: EPS: ₹1.59 (vs ₹8.10 in 1Q 2025)First quarter 2026 results: EPS: ₹1.59 (down from ₹8.10 in 1Q 2025). Revenue: ₹11.1b (down 2.9% from 1Q 2025). Net income: ₹981.6m (down 80% from 1Q 2025). Profit margin: 8.9% (down from 44% in 1Q 2025). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has increased by 14% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Aug 03+ 1 more updateFinolex Industries Limited Announces Resignation of Saurabh Dhanorkar as Managing Director, Effective October 25, 2025Finolex Industries Limited at its board meeting held on August 2, 2025, approved Mr. Saurabh Dhanorkar, Managing Director of the Company, will attain the age of 70 years on October 26, 2025. In accordance with the prescribed age limit as stipulated under the Companies Act, 2013 and SEBI Listing Regulations, Mr. Dhanorkar has conveyed his decision not to seek reappointment and will accordingly relinquish his position as Managing Director effective from the close of business hours on October 25, 2025.お知らせ • Jul 25Finolex Industries Limited to Report Q1, 2026 Results on Aug 02, 2025Finolex Industries Limited announced that they will report Q1, 2026 results at 4:00 PM, Indian Standard Time on Aug 02, 2025Reported Earnings • May 24Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2025 results: EPS: ₹12.94 (up from ₹7.66 in FY 2024). Revenue: ₹43.9b (up 1.6% from FY 2024). Net income: ₹8.00b (up 69% from FY 2024). Profit margin: 18% (up from 11% in FY 2024). Revenue missed analyst estimates by 2.8%. Earnings per share (EPS) exceeded analyst estimates by 3.2%. Revenue is forecast to grow 9.9% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.お知らせ • May 24+ 2 more updatesFinolex Industries Limited Recommends Final Dividend for the Financial Year Ended March 31, 2025Finolex Industries Limited at its Board Meeting Held on 23 May 2025 recommended a final dividend of INR 2 per fully paid-up equity share of face value of INR 2 each for the Financial Year ended 31st March 2025, subject to deduction of tax, as applicable and approval of Members at the ensuing Forty Forth Annual General Meeting; (The Company will inform the date of the Forty-Fourth (44) Annual General Meeting and the dividend payment date in due course).お知らせ • May 16Finolex Industries Limited to Report Q4, 2025 Results on May 23, 2025Finolex Industries Limited announced that they will report Q4, 2025 results on May 23, 2025お知らせ • Mar 03Finolex Industries Limited Appoints Rambabu Sanka as President - TechnicalFinolex Industries Limited approved the appointment of Mr. Rambabu Sanka as President - Technical and Senior Management Personnel of the Company, with effect from 3rd March 2025. Mr. Rambabu Sanka is a Senior Executive with 39 years of comprehensive experience in the Chemical Manufacturing Sector, including 31 years dedicated to VCM/PVC production. His expertise encompasses leadership in technical services, process optimization, debottlenecking, and the management of large-scale plant expansions and operations. He has a proven track record in the commissioning of advanced chemical facilities, enhancing operational efficiency, and achieving significant increases in production. He is skilled in production planning, budgeting, variance analysis, and managing shutdowns and turnarounds, all while prioritizing safety and operational continuity. In his prior positions, he has overseen VCM and PVC manufacturing operations (INEOS Technology), serving as Vice President with Reliance Industries Limited, and held the role of Executive Vice President, Technical Services at TCI Sanmar Chemicals S.A.E.お知らせ • Feb 15Finolex Industries Limited Announces Resignation of Harish Dash as Chief Information OfficerFinolex Industries Limited announced that Mr. Harish Dash, Chief Information Officer (Senior Management Personnel) of the company, has tendered his resignation from the services of the company due to personal reasons, with effect from the close of business hours on 14 February, 2025.Price Target Changed • Feb 12Price target decreased by 12% to ₹268Down from ₹304, the current price target is an average from 15 analysts. New target price is 38% above last closing price of ₹195. Stock is down 11% over the past year. The company is forecast to post earnings per share of ₹12.40 for next year compared to ₹7.66 last year.New Risk • Feb 11New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 7.1% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 7.1% per year for the foreseeable future. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results.Reported Earnings • Feb 07Third quarter 2025 earnings released: EPS: ₹1.52 (vs ₹1.54 in 3Q 2024)Third quarter 2025 results: EPS: ₹1.52 (down from ₹1.54 in 3Q 2024). Revenue: ₹10.5b (up 2.9% from 3Q 2024). Net income: ₹940.2m (down 1.4% from 3Q 2024). Profit margin: 9.0% (down from 9.4% in 3Q 2024). Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.お知らせ • Jan 30Finolex Industries Limited to Report Q3, 2025 Results on Feb 06, 2025Finolex Industries Limited announced that they will report Q3, 2025 results on Feb 06, 2025Valuation Update With 7 Day Price Move • Jan 13Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹207, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 8.7% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹116 per share.お知らせ • Nov 22Finolex Industries Limited Appoints Saurabh Dhanorkar as Managing DirectorFinolex Industries Limited has approved the appointment of Saurabh Dhanorkar as Managing Director for a period of two years with effect from 21st November 2024. Dhanorkar has been associated with the Company since 1983 in various roles and was Managing Director until 2012 when he retired. He is a qualified Chartered Accountant and has contributed significantly to the expansion of the Company from a INR 20 million pipes manufacturing company to a multi-location petrochemicals and plastics processing giant. He retired as Managing Director in 2016 and has been associated with the Company as a Non-Executive Director for the past eight years. Executive Chairman, Prakash Chhabria, emphasized the importance of this leadership change, praising Dhanorkar's vast experience in accounting, finance, commercial, strategy, marketing, and general management. He expressed confidence in Dhanorkar's ability to lead Finolex into its next phase of growth and profitability, citing his client-centric approach, growth mindset, and commitment to the company's values and looks forward to setting new benchmarks under his leadership. The Board at their meeting held on 24th October 2024, considered the recommendation of the Nomination & Remuneration Committee, and approved the appointment of Saurabh Dhanorkar as the Managing Director w.e.f. 21st November 2024, necessary disclosures of which have already been filed with the Stock Exchanges. Ajit Venkataraman will be stepping down as Managing Director at the close of business hours on 20th November 2024.New Risk • Nov 16New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 0.5% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 0.5% per year for the foreseeable future. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results.Board Change • Nov 01High number of new directorsThere are 8 new directors who have joined the board in the last 3 years. Independent Director Munesh Khanna was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Oct 26Second quarter 2025 earnings: EPS and revenues miss analyst expectationsSecond quarter 2025 results: EPS: ₹0.66 (down from ₹1.58 in 2Q 2024). Revenue: ₹9.11b (up 3.2% from 2Q 2024). Net income: ₹406.7m (down 59% from 2Q 2024). Profit margin: 4.5% (down from 11% in 2Q 2024). Revenue missed analyst estimates by 10%. Earnings per share (EPS) also missed analyst estimates by 68%. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.お知らせ • Oct 17Finolex Industries Limited to Report Q2, 2025 Results on Oct 24, 2024Finolex Industries Limited announced that they will report Q2, 2025 results on Oct 24, 2024Upcoming Dividend • Sep 03Upcoming dividend of ₹2.50 per shareEligible shareholders must have bought the stock before 10 September 2024. Payment date: 03 October 2024. Payout ratio is a comfortable 33% and this is well supported by cash flows. Trailing yield: 0.8%. Lower than top quartile of Indian dividend payers (1.1%). Higher than average of industry peers (0.6%).お知らせ • Aug 29Finolex Industries Limited, Annual General Meeting, Sep 18, 2024Finolex Industries Limited, Annual General Meeting, Sep 18, 2024, at 16:00 Indian Standard Time.Price Target Changed • Jul 30Price target increased by 9.4% to ₹310Up from ₹283, the current price target is an average from 16 analysts. New target price is approximately in line with last closing price of ₹322. Stock is up 63% over the past year. The company is forecast to post earnings per share of ₹14.67 for next year compared to ₹7.66 last year.Reported Earnings • Jul 28First quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFirst quarter 2025 results: EPS: ₹8.10 (up from ₹1.86 in 1Q 2024). Revenue: ₹12.0b (up 1.4% from 1Q 2024). Net income: ₹5.01b (up 334% from 1Q 2024). Profit margin: 42% (up from 9.8% in 1Q 2024). Revenue missed analyst estimates by 14%. Earnings per share (EPS) exceeded analyst estimates. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has increased by 22% per year, which means it is well ahead of earnings.お知らせ • Jul 21Finolex Industries Limited to Report Q1, 2025 Results on Jul 27, 2024Finolex Industries Limited announced that they will report Q1, 2025 results on Jul 27, 2024Price Target Changed • May 15Price target increased by 10% to ₹268Up from ₹243, the current price target is an average from 15 analysts. New target price is 12% below last closing price of ₹305. Stock is up 62% over the past year. The company is forecast to post earnings per share of ₹11.74 for next year compared to ₹7.66 last year.Reported Earnings • May 11Full year 2024 earnings released: EPS: ₹7.66 (vs ₹4.06 in FY 2023)Full year 2024 results: EPS: ₹7.66 (up from ₹4.06 in FY 2023). Revenue: ₹45.0b (up 2.3% from FY 2023). Net income: ₹4.74b (up 89% from FY 2023). Profit margin: 11% (up from 5.7% in FY 2023). The increase in margin was primarily driven by lower expenses. Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has increased by 21% per year, which means it is well ahead of earnings.お知らせ • May 11+ 1 more updateFinolex Industries Limited Recommends Final Dividend for the Financial Year Ended March 31, 2024Finolex Industries Limited Recommended a final dividend of INR 2.50/- per fully paid-up equity shares of INR 2/- each (face value) i.e. 125% for the financial year ended 31st March, 2024, subject to deduction of tax, as applicable and approval of Members at the ensuing Forty Third Annual General Meeting.お知らせ • May 05Finolex Industries Limited to Report Q4, 2024 Results on May 10, 2024Finolex Industries Limited announced that they will report Q4, 2024 results on May 10, 2024お知らせ • Apr 12Finolex Industries Limited Announces the Resignation of Niraj Kedia as Chief Financial Officer, Effective June 30, 2024Finolex Industries Limited announced the resignation of Mr. Niraj Kedia as Chief Financial Officer (CFO) and Key Managerial Personnel, his last date with the Company would be June 30, 2024. Due to personal family commitments.Valuation Update With 7 Day Price Move • Mar 27Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹249, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 107% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹124 per share.Price Target Changed • Jan 24Price target increased by 7.9% to ₹243Up from ₹225, the current price target is an average from 14 analysts. New target price is 5.8% above last closing price of ₹230. Stock is up 38% over the past year. The company is forecast to post earnings per share of ₹6.98 for next year compared to ₹4.05 last year.Reported Earnings • Jan 21Third quarter 2024 earnings released: EPS: ₹1.54 (vs ₹1.28 in 3Q 2023)Third quarter 2024 results: EPS: ₹1.54 (up from ₹1.28 in 3Q 2023). Revenue: ₹10.2b (down 9.3% from 3Q 2023). Net income: ₹954.0m (up 20% from 3Q 2023). Profit margin: 9.4% (up from 7.1% in 3Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 24% per year, which means it is well ahead of earnings.お知らせ • Jan 19Finolex Industries Limited Designates Swad Deshpande, Head - Purchase as Senior Management PersonnelThe Board of Directors of Finolex Industries Limited at its meeting held on 18th January, 2024, the Board of Directors has designated Mr. Swad Deshpande, Head - Purchase as Senior Management Personnel of the Company with effect from 18th January, 2024. He comes with 30+ years of experience with various large MNCs and Indian Companies including Greaves Electric Mobility Limited, Tata Motors Ltd., Samsung India Electronics Private Limited and Philips Electronics India Limited.お知らせ • Jan 11Finolex Industries Limited to Report Q3, 2024 Results on Jan 18, 2024Finolex Industries Limited announced that they will report Q3, 2024 results on Jan 18, 2024Reported Earnings • Oct 22Second quarter 2024 earnings released: EPS: ₹1.58 (vs ₹1.54 loss in 2Q 2023)Second quarter 2024 results: EPS: ₹1.58 (up from ₹1.54 loss in 2Q 2023). Revenue: ₹9.45b (flat on 2Q 2023). Net income: ₹979.6m (up ₹1.93b from 2Q 2023). Profit margin: 10% (up from net loss in 2Q 2023). Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 29% per year, which means it is well ahead of earnings.お知らせ • Oct 14Finolex Industries Limited to Report Q2, 2024 Results on Oct 21, 2023Finolex Industries Limited announced that they will report Q2, 2024 results at 4:00 PM, Indian Standard Time on Oct 21, 2023お知らせ • Aug 31Finolex Industries Limited Approves Dividend for the Financial Year Ended March 31, 2023Finolex Industries Limited approved dividend of 1.50 per equity share for the financial year ended March 31, 2023 at its AGM held on August 28, 2023.Upcoming Dividend • Aug 14Upcoming dividend of ₹1.50 per share at 0.7% yieldEligible shareholders must have bought the stock before 21 August 2023. Payment date: 11 September 2023. Payout ratio is a comfortable 37% but the company is paying out more than the cash it is generating. Trailing yield: 0.7%. Lower than top quartile of Indian dividend payers (1.4%). Lower than average of industry peers (0.9%).お知らせ • Aug 06Finolex Industries Limited, Annual General Meeting, Aug 28, 2023Finolex Industries Limited, Annual General Meeting, Aug 28, 2023, at 16:00 Indian Standard Time. Agenda: To receive, consider, approve and adopt the audited Standalone Financial Statements of the Company for the financial year ended March 31, 2023 and the Reports of the Board of Directors and the Auditors thereon; to receive, consider, approve and adopt the audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2023 and the Report of the Auditors thereon; to declare a final dividend; to appoint a Director in place of Mr. Saurabh S. Dhanorkar who retires by rotation, and being eligible, offers himself for e-appointment and to consider other matters.Reported Earnings • Jul 20First quarter 2024 earnings released: EPS: ₹1.86 (vs ₹1.60 in 1Q 2023)First quarter 2024 results: EPS: ₹1.86 (up from ₹1.60 in 1Q 2023). Revenue: ₹12.2b (up 2.5% from 1Q 2023). Net income: ₹1.15b (up 16% from 1Q 2023). Profit margin: 9.5% (up from 8.3% in 1Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 10.0% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 26% per year, which means it is well ahead of earnings.お知らせ • Jul 13Finolex Industries Limited to Report Q1, 2024 Results on Jul 19, 2023Finolex Industries Limited announced that they will report Q1, 2024 results on Jul 19, 2023Board Change • Jun 05Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 6 experienced directors. 2 highly experienced directors. Director of Technical & Additional Whole-Time Director Saumya Chakraborty was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Jun 01Finolex Industries Limited Announces Cessation of Ajit Venkataraman as Chief Executive OfficerFinolex Industries Limited announced that In term of subject referred matter and in continuation to previous communication dated 22nd May, 2023, this is to inform that: Consequent to appointment of Mr. Ajit Venkataraman as Managing Director of the Company from 1st June, 2023, he ceased as Chief Executive Officer of the Company from the close of business hours of 31st May, 2023.Price Target Changed • May 30Price target increased by 8.3% to ₹209Up from ₹193, the current price target is an average from 12 analysts. New target price is 20% above last closing price of ₹175. Stock is up 11% over the past year. The company is forecast to post earnings per share of ₹8.87 for next year compared to ₹4.04 last year.お知らせ • May 23+ 1 more updateFinolex Industries Limited Recommends Final Dividend for the Financial Year Ended March 31, 2023Finolex Industries Limited at its board meeting held on May 22, 2023 recommended a final dividend of INR 1.50 per fully paid-up equity shares of INR 2 each (face value) i.e. 75% for the financial year ended 31st March, 2023, subject to deduction of tax, as applicable and approval of Members at the upcoming forty-second Annual General Meeting.Reported Earnings • May 23Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: EPS: ₹4.04 (down from ₹16.94 in FY 2022). Revenue: ₹45.2b (down 2.8% from FY 2022). Net income: ₹2.51b (down 76% from FY 2022). Profit margin: 5.5% (down from 23% in FY 2022). The decrease in margin was primarily driven by higher expenses. Revenue missed analyst estimates by 2.1%. Earnings per share (EPS) also missed analyst estimates by 5.4%. Revenue is forecast to grow 9.1% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 31% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • May 17Finolex Industries Limited to Report Q4, 2023 Results on May 22, 2023Finolex Industries Limited announced that they will report Q4, 2023 results on May 22, 2023Reported Earnings • Feb 08Third quarter 2023 earnings released: EPS: ₹1.28 (vs ₹2.86 in 3Q 2022)Third quarter 2023 results: EPS: ₹1.28 (down from ₹2.86 in 3Q 2022). Revenue: ₹12.2b (up 21% from 3Q 2022). Net income: ₹795.4m (down 55% from 3Q 2022). Profit margin: 6.5% (down from 18% in 3Q 2022). Revenue is expected to decline by 2.6% p.a. on average during the next 3 years, while revenues in the Chemicals industry in India are expected to grow by 12%. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.お知らせ • Jan 28Finolex Industries Limited to Report Q3, 2023 Results on Feb 04, 2023Finolex Industries Limited announced that they will report Q3, 2023 results on Feb 04, 2023Valuation Update With 7 Day Price Move • Nov 07Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹157, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 41% over the past three years.Board Change • Oct 31High number of new directorsDirector of Technical & Additional Whole-Time Director Saumya Chakraborty was the last director to join the board, commencing their role in 2022.Major Estimate Revision • Oct 28Consensus forecasts updatedThe consensus outlook for 2023 has been updated. 2023 revenue forecast increased from ₹40.9b to ₹41.6b. EPS estimate fell from ₹7.00 to ₹3.90 per share. Net income forecast to shrink 44% next year vs 22% growth forecast for Chemicals industry in India . Consensus price target down from ₹174 to ₹168. Share price fell 3.8% to ₹133 over the past week.Reported Earnings • Oct 23Second quarter 2023 earnings released: ₹1.54 loss per share (vs ₹3.76 profit in 2Q 2022)Second quarter 2023 results: ₹1.54 loss per share (down from ₹3.76 profit in 2Q 2022). Revenue: ₹9.80b (down 9.5% from 2Q 2022). Net loss: ₹953.8m (down 141% from profit in 2Q 2022). Revenue is forecast to grow 1.6% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.お知らせ • Oct 15Finolex Industries Limited to Report Q2, 2023 Results on Oct 21, 2022Finolex Industries Limited announced that they will report Q2, 2023 results on Oct 21, 2022Major Estimate Revision • Sep 06Consensus forecasts updatedThe consensus outlook for 2023 has been updated. 2023 revenue forecast increased from ₹39.6b to ₹40.9b. EPS estimate fell from ₹7.80 to ₹7.00 per share. Net income forecast to shrink 45% next year vs 22% growth forecast for Chemicals industry in India . Consensus price target broadly unchanged at ₹177. Share price was steady at ₹153 over the past week.お知らせ • Sep 01+ 1 more updateFinolex Industries Limited Approves Special Dividend for the Financial Year Ended March 31, 2022Finolex Industries Limited approved the declaration of a special dividend of INR 2 per equity share for the financial year ended March 31, 2022, at its forty-first annual general meeting held on August 30, 2022.Upcoming Dividend • Aug 15Upcoming dividend of ₹4.00 per shareEligible shareholders must have bought the stock before 22 August 2022. Payment date: 29 September 2022. Payout ratio is a comfortable 12% and this is well supported by cash flows. Trailing yield: 2.8%. Within top quartile of Indian dividend payers (1.7%). Higher than average of industry peers (0.7%).お知らせ • Aug 07Finolex Industries Limited, Annual General Meeting, Aug 30, 2022Finolex Industries Limited, Annual General Meeting, Aug 30, 2022, at 16:00 Indian Standard Time. Agenda: To consider the audited standalone financial statements of the Company for the financial year ended March 31, 2022, together with the Reports of the Board of Directors and the Auditors thereon; to declare final dividend of 2 per equity share and special dividend of 2 per equity share for the financial year ended March 31, 2022; to appoint a Director in place of Mrs. Ritu P. Chhabria(DIN: 00062144) who retires by rotation, and being eligible, offers herself for re-appointment; and to consider other matters.Major Estimate Revision • Jul 29Consensus revenue estimates fall by 15%The consensus outlook for revenues in 2023 has deteriorated. 2023 revenue forecast decreased from ₹46.1b to ₹39.1b. EPS estimate fell from ₹9.50 to ₹7.00 per share. Net income forecast to shrink 42% next year vs 24% growth forecast for Chemicals industry in India . Consensus price target down from ₹204 to ₹183. Share price fell 5.1% to ₹133 over the past week.Price Target Changed • Jul 26Price target decreased to ₹188Down from ₹204, the current price target is an average from 7 analysts. New target price is 43% above last closing price of ₹131. Stock is down 25% over the past year. The company is forecast to post earnings per share of ₹7.00 for next year compared to ₹16.94 last year.お知らせ • Jul 25+ 1 more updateFinolex Industries Limited Recommends Special Dividend for the Year Ended 31 March 2022Finolex Industries Limited at the Board of Directors meeting held on 18th May, 2022 recommended a special dividend of INR 2 (100%) per equity share of the face value of INR 2 each, for the financial year ended 31st March 2022. The said dividend, as recommended by the Board, if declared at the upcoming 41st Annual General Meeting, will be paid within 30 days of the date of its declaration to eligible Shareholders holding shares as on record datewhich will be communicated separately.お知らせ • Jul 23Finolex Industries Limited Appoints Ajit Venkataraman as Chief Executive Officer, Effective August 1, 2022Finolex Industries Limited at its board meeting held on July 22, 2022, approved appointment of Ajit Venkataraman as Chief Executive Officer and Key Managerial Personnel of the Company with effect from August 1, 2022. Ajit Venkataraman is an MBA from University of Michigan and brings in 27 years of rich experience across US, India & South East Asia. Ajit Venkataraman comes with diverse industry experience both national and global, and an impressive track record of delivering performance consistently through the years. He has been instrumental in running multicultural organization m Automobile and Logistics industry. His strength lies in strategic planning, managing JVs, new market entry, business turnaround, product development and management. He was previously associated with Tecumseh, Kearney, Tata Motors & APM Terminals Inland Services Asia and Greaves Cotton Limited.Reported Earnings • Jul 23First quarter 2023 earnings released: EPS: ₹1.60 (vs ₹2.35 in 1Q 2022)First quarter 2023 results: EPS: ₹1.60 (down from ₹2.35 in 1Q 2022). Revenue: ₹12.1b (up 26% from 1Q 2022). Net income: ₹992.2m (down 32% from 1Q 2022). Profit margin: 8.2% (down from 15% in 1Q 2022). Over the next year, revenue is expected to shrink by 7.2% compared to a 17% growth forecast for the industry in India. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.Price Target Changed • Jul 22Price target decreased to ₹200Down from ₹216, the current price target is an average from 7 analysts. New target price is 43% above last closing price of ₹140. Stock is down 21% over the past year. The company is forecast to post earnings per share of ₹9.50 for next year compared to ₹16.94 last year.お知らせ • Jul 14Finolex Industries Limited to Report Q1, 2023 Results on Jul 22, 2022Finolex Industries Limited announced that they will report Q1, 2023 results at 3:30 PM, Indian Standard Time on Jul 22, 2022お知らせ • Jun 03Sanjay S. Math Ceases to Be Director of Finolex Industries LimitedFinolex Industries Limited informed that Mr. Sanjay S. Math has ceased to be Director and Key Managerial Personnel (KMP) of the Company with effect from closing of business hours of 31 May, 2022 .Reported Earnings • May 20Full year 2022 earnings: EPS and revenues exceed analyst expectationsFull year 2022 results: EPS: ₹16.94 (up from ₹11.89 in FY 2021). Revenue: ₹46.5b (up 34% from FY 2021). Net income: ₹10.5b (up 43% from FY 2021). Profit margin: 23% (up from 21% in FY 2021). Revenue exceeded analyst estimates by 9.0%. Earnings per share (EPS) also surpassed analyst estimates by 45%. Over the next year, revenue is forecast to grow 4.5%, compared to a 21% growth forecast for the industry in India. Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth.お知らせ • May 19+ 3 more updatesFinolex Industries Limited Announces Retirement of Sanjay S. Math, Managing DirectorFinolex Industries Limited at its board meeting held on May 18, 2022, approved Retirement of Mr. Sanjay S. Math, Managing Director with effective May 31, 2022.Board Change • Apr 27High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director of Finance & Additional Whole-time Director Anil Whabi was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Jan 26Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindThird quarter 2022 results: EPS: ₹2.86 (down from ₹4.18 in 3Q 2021). Revenue: ₹10.2b (down 4.0% from 3Q 2021). Net income: ₹1.77b (down 32% from 3Q 2021). Profit margin: 17% (down from 24% in 3Q 2021). The decrease in margin was primarily driven by higher expenses. Revenue missed analyst estimates by 34%. Earnings per share (EPS) exceeded analyst estimates by 30%. Over the next year, revenue is forecast to stay flat compared to a 19% growth forecast for the industry in India. Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth.Price Target Changed • Nov 02Price target increased to ₹220Up from ₹201, the current price target is an average from 5 analysts. New target price is approximately in line with last closing price of ₹228. Stock is up 106% over the past year. The company is forecast to post earnings per share of ₹11.57 for next year compared to ₹11.89 last year.Reported Earnings • Nov 01Second quarter 2022 earnings released: EPS ₹3.76 (vs ₹1.98 in 2Q 2021)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2022 results: Revenue: ₹11.1b (up 90% from 2Q 2021). Net income: ₹2.33b (up 90% from 2Q 2021). Profit margin: 21% (in line with 2Q 2021).Valuation Update With 7 Day Price Move • Oct 04Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹225, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 33x in the Chemicals industry in India. Total returns to shareholders of 134% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹156 per share.お知らせ • Sep 24Finolex Industries Limited Approves Special Dividend for the Financial Year Ended 31 March, 2021Finolex Industries Limited at its annual general meeting of the Members of the Company was held on 22nd September, 2021, approved to declare a special dividend of INR 2 per equity share for the financial year ended 31 March, 2021.Price Target Changed • Sep 01Price target increased to ₹196Up from ₹180, the current price target is an average from 6 analysts. New target price is 17% above last closing price of ₹168. Stock is up 66% over the past year.Reported Earnings • Aug 02First quarter 2022 earnings released: EPS ₹2.35 (vs ₹0.91 in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹9.81b (up 75% from 1Q 2021). Net income: ₹1.46b (up 157% from 1Q 2021). Profit margin: 15% (up from 10% in 1Q 2021). The increase in margin was driven by higher revenue.Major Estimate Revision • Jul 03Consensus EPS estimates increase to ₹8.52The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from ₹35.5b to ₹38.7b. EPS estimate increased from ₹7.69 to ₹8.52 per share. Net income forecast to shrink 28% next year vs 18% growth forecast for Chemicals industry in India . Consensus price target up from ₹150 to ₹178. Share price rose 5.8% to ₹184 over the past week.業績と収益の成長予測BSE:500940 - アナリストの将来予測と過去の財務データ ( )INR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/202957,1377,2563,4736,28243/31/202849,4856,2354,1396,791103/31/202745,5575,5015,2156,622103/31/202641,1345,9911,2681,918N/A12/31/202539,7145,024N/AN/AN/A9/30/202540,7494,803-94779N/A6/30/202540,4463,975N/AN/AN/A3/31/202541,4208,0002,6723,827N/A12/31/202442,0568,004N/AN/AN/A9/30/202442,2408,0175,2976,118N/A6/30/202442,7888,590N/AN/AN/A3/31/202443,1744,7362,6703,533N/A12/31/202342,2314,760N/AN/AN/A9/30/202343,2844,6021,4963,087N/A6/30/202343,8642,668N/AN/AN/A3/31/202343,9712,5071,3893,077N/A12/31/202248,5065,785N/AN/AN/A9/30/202247,3026,7642,1273,254N/A6/30/202248,71810,050N/AN/AN/A3/31/202246,47310,5145,3766,220N/A12/31/202143,0328,551N/AN/AN/A9/30/202143,6419,3706,9537,750N/A6/30/202138,6678,266N/AN/AN/A3/31/202134,6237,3788,7619,410N/A12/31/202029,8084,976N/AN/AN/A9/30/202026,1343,368174706N/A6/30/202026,0423,162N/AN/AN/A3/31/202029,8453,3274501,063N/A12/31/201931,8413,714N/AN/AN/A9/30/201932,4133,526N/A3,772N/A6/30/201932,0733,282N/AN/AN/A3/31/201930,9133,673N/A3,910N/A3/31/201827,3783,063N/A3,384N/A3/31/201726,0243,548N/A2,517N/A3/31/201624,8192,578N/A5,690N/A12/31/201524,3241,828N/AN/AN/A9/30/201525,292960N/AN/AN/A6/30/201524,493678N/AN/AN/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 500940の予測収益成長率 (年間5.6% ) は 貯蓄率 ( 6.9% ) を下回っています。収益対市場: 500940の収益 ( 5.6% ) Indian市場 ( 16.1% ) よりも低い成長が予測されています。高成長収益: 500940の収益は増加すると予測されていますが、大幅には増加しません。収益対市場: 500940の収益 ( 10.1% ) Indian市場 ( 10.9% ) よりも低い成長が予測されています。高い収益成長: 500940の収益 ( 10.1% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 500940の 自己資本利益率 は、3年後には低くなると予測されています ( 10.2 %)。成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/17 19:49終値2026/06/17 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Finolex Industries Limited 10 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。21 アナリスト機関Amit Srivastava360 ONE Capital Market Private LimitedUtkarsh NopanyAnand Rathi Shares and Stock Brokers Limitednull nullAnand Rathi Shares and Stock Brokers Limited18 その他のアナリストを表示
Price Target Changed • Feb 14Price target decreased by 8.2% to ₹206Down from ₹224, the current price target is an average from 15 analysts. New target price is 8.6% above last closing price of ₹189. Stock is down 0.5% over the past year. The company is forecast to post earnings per share of ₹7.94 for next year compared to ₹12.94 last year.
Price Target Changed • Feb 12Price target decreased by 12% to ₹268Down from ₹304, the current price target is an average from 15 analysts. New target price is 38% above last closing price of ₹195. Stock is down 11% over the past year. The company is forecast to post earnings per share of ₹12.40 for next year compared to ₹7.66 last year.
Price Target Changed • Jul 30Price target increased by 9.4% to ₹310Up from ₹283, the current price target is an average from 16 analysts. New target price is approximately in line with last closing price of ₹322. Stock is up 63% over the past year. The company is forecast to post earnings per share of ₹14.67 for next year compared to ₹7.66 last year.
Price Target Changed • May 15Price target increased by 10% to ₹268Up from ₹243, the current price target is an average from 15 analysts. New target price is 12% below last closing price of ₹305. Stock is up 62% over the past year. The company is forecast to post earnings per share of ₹11.74 for next year compared to ₹7.66 last year.
Price Target Changed • Jan 24Price target increased by 7.9% to ₹243Up from ₹225, the current price target is an average from 14 analysts. New target price is 5.8% above last closing price of ₹230. Stock is up 38% over the past year. The company is forecast to post earnings per share of ₹6.98 for next year compared to ₹4.05 last year.
Price Target Changed • May 30Price target increased by 8.3% to ₹209Up from ₹193, the current price target is an average from 12 analysts. New target price is 20% above last closing price of ₹175. Stock is up 11% over the past year. The company is forecast to post earnings per share of ₹8.87 for next year compared to ₹4.04 last year.
Reported Earnings • May 27Full year 2026 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2026 results: EPS: ₹9.69 (down from ₹12.94 in FY 2025). Revenue: ₹43.2b (up 4.4% from FY 2025). Net income: ₹5.99b (down 25% from FY 2025). Profit margin: 14% (down from 19% in FY 2025). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 1.7%. Earnings per share (EPS) exceeded analyst estimates by 15%. Revenue is forecast to grow 7.0% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
お知らせ • May 27Finolex Industries Limited Recommends Special Dividend for the Year Ended March 31, 2026Finolex Industries Limited announced that the Board of Directors of the Company held its meeting on 26 May 2026. Company Recommended a special dividend of INR 0.75 (37.50%) per equity share of INR 2/- each, aggregating to INR 2.75 (137.50%) per equity share of INR 2/- each for the year ended March 31, 2026, subject to deduction of tax, as applicable and approval of Members at the ensuing 45th Annual General Meeting; (The Company will inform the date of the Forty-Fifth (45th) Annual General Meeting and the dividend payment date in due course).
お知らせ • May 26Finolex Industries Limited Recommends Final Dividend for the Year Ended March 31, 2026Finolex Industries Limited announced that the Board of Directors of the Company held its meeting on 26 May 2026. Company Recommended a final dividend of INR 2 (100%) per equity share of INR 2/- each aggregating to INR 2.75 (137.50%) per equity share of INR 2/- each for the year ended March 31, 2026, subject to deduction of tax, as applicable and approval of Members at the ensuing 45th Annual General Meeting; (The Company will inform the date of the Forty-Fifth (45th) Annual General Meeting and the dividend payment date in due course.).
お知らせ • May 19Finolex Industries Limited to Report Q4, 2026 Results on May 26, 2026Finolex Industries Limited announced that they will report Q4, 2026 results on May 26, 2026
Price Target Changed • Feb 14Price target decreased by 8.2% to ₹206Down from ₹224, the current price target is an average from 15 analysts. New target price is 8.6% above last closing price of ₹189. Stock is down 0.5% over the past year. The company is forecast to post earnings per share of ₹7.94 for next year compared to ₹12.94 last year.
Reported Earnings • Feb 01Third quarter 2026 earnings released: EPS: ₹1.88 (vs ₹1.52 in 3Q 2025)Third quarter 2026 results: EPS: ₹1.88 (up from ₹1.52 in 3Q 2025). Revenue: ₹9.50b (down 5.1% from 3Q 2025). Net income: ₹1.16b (up 24% from 3Q 2025). Profit margin: 12% (up from 9.4% in 3Q 2025). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
お知らせ • Jan 27Finolex Industries Limited to Report Q3, 2026 Results on Jan 31, 2026Finolex Industries Limited announced that they will report Q3, 2026 results at 4:00 PM, Indian Standard Time on Jan 31, 2026
Reported Earnings • Nov 08Second quarter 2026 earnings released: EPS: ₹2.00 (vs ₹0.66 in 2Q 2025)Second quarter 2026 results: EPS: ₹2.00 (up from ₹0.66 in 2Q 2025). Revenue: ₹9.16b (up 11% from 2Q 2025). Net income: ₹1.24b (up 204% from 2Q 2025). Profit margin: 14% (up from 4.9% in 2Q 2025). Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 7% per year.
お知らせ • Oct 28Finolex Industries Limited to Report Q2, 2026 Results on Nov 07, 2025Finolex Industries Limited announced that they will report Q2, 2026 results on Nov 07, 2025
お知らせ • Sep 15+ 1 more updateFinolex Industries Limited Approves Appointment of Udipt Agarwal as Managing DirectorFinolex Industries Limited at its AGM held on September 12, 2025, approved the appointment of Mr. Udipt Agarwal as a Managing Director of the Company.
Declared Dividend • Aug 22Dividend of ₹3.60 announcedShareholders will receive a dividend of ₹3.60. Ex-date: 4th September 2025 Payment date: 12th October 2025 Dividend yield will be 1.7%, which is higher than the industry average of 0.8%. Sustainability & Growth Dividend is well covered by both earnings (15% earnings payout ratio) and cash flows (46% cash payout ratio). The dividend has increased by an average of 3.6% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 79% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • Aug 04Finolex Industries Limited, Annual General Meeting, Sep 12, 2025Finolex Industries Limited, Annual General Meeting, Sep 12, 2025.
New Risk • Aug 03New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 9.8% Last year net profit margin: 20% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (9.8% net profit margin).
Reported Earnings • Aug 03First quarter 2026 earnings released: EPS: ₹1.59 (vs ₹8.10 in 1Q 2025)First quarter 2026 results: EPS: ₹1.59 (down from ₹8.10 in 1Q 2025). Revenue: ₹11.1b (down 2.9% from 1Q 2025). Net income: ₹981.6m (down 80% from 1Q 2025). Profit margin: 8.9% (down from 44% in 1Q 2025). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has increased by 14% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Aug 03+ 1 more updateFinolex Industries Limited Announces Resignation of Saurabh Dhanorkar as Managing Director, Effective October 25, 2025Finolex Industries Limited at its board meeting held on August 2, 2025, approved Mr. Saurabh Dhanorkar, Managing Director of the Company, will attain the age of 70 years on October 26, 2025. In accordance with the prescribed age limit as stipulated under the Companies Act, 2013 and SEBI Listing Regulations, Mr. Dhanorkar has conveyed his decision not to seek reappointment and will accordingly relinquish his position as Managing Director effective from the close of business hours on October 25, 2025.
お知らせ • Jul 25Finolex Industries Limited to Report Q1, 2026 Results on Aug 02, 2025Finolex Industries Limited announced that they will report Q1, 2026 results at 4:00 PM, Indian Standard Time on Aug 02, 2025
Reported Earnings • May 24Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2025 results: EPS: ₹12.94 (up from ₹7.66 in FY 2024). Revenue: ₹43.9b (up 1.6% from FY 2024). Net income: ₹8.00b (up 69% from FY 2024). Profit margin: 18% (up from 11% in FY 2024). Revenue missed analyst estimates by 2.8%. Earnings per share (EPS) exceeded analyst estimates by 3.2%. Revenue is forecast to grow 9.9% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.
お知らせ • May 24+ 2 more updatesFinolex Industries Limited Recommends Final Dividend for the Financial Year Ended March 31, 2025Finolex Industries Limited at its Board Meeting Held on 23 May 2025 recommended a final dividend of INR 2 per fully paid-up equity share of face value of INR 2 each for the Financial Year ended 31st March 2025, subject to deduction of tax, as applicable and approval of Members at the ensuing Forty Forth Annual General Meeting; (The Company will inform the date of the Forty-Fourth (44) Annual General Meeting and the dividend payment date in due course).
お知らせ • May 16Finolex Industries Limited to Report Q4, 2025 Results on May 23, 2025Finolex Industries Limited announced that they will report Q4, 2025 results on May 23, 2025
お知らせ • Mar 03Finolex Industries Limited Appoints Rambabu Sanka as President - TechnicalFinolex Industries Limited approved the appointment of Mr. Rambabu Sanka as President - Technical and Senior Management Personnel of the Company, with effect from 3rd March 2025. Mr. Rambabu Sanka is a Senior Executive with 39 years of comprehensive experience in the Chemical Manufacturing Sector, including 31 years dedicated to VCM/PVC production. His expertise encompasses leadership in technical services, process optimization, debottlenecking, and the management of large-scale plant expansions and operations. He has a proven track record in the commissioning of advanced chemical facilities, enhancing operational efficiency, and achieving significant increases in production. He is skilled in production planning, budgeting, variance analysis, and managing shutdowns and turnarounds, all while prioritizing safety and operational continuity. In his prior positions, he has overseen VCM and PVC manufacturing operations (INEOS Technology), serving as Vice President with Reliance Industries Limited, and held the role of Executive Vice President, Technical Services at TCI Sanmar Chemicals S.A.E.
お知らせ • Feb 15Finolex Industries Limited Announces Resignation of Harish Dash as Chief Information OfficerFinolex Industries Limited announced that Mr. Harish Dash, Chief Information Officer (Senior Management Personnel) of the company, has tendered his resignation from the services of the company due to personal reasons, with effect from the close of business hours on 14 February, 2025.
Price Target Changed • Feb 12Price target decreased by 12% to ₹268Down from ₹304, the current price target is an average from 15 analysts. New target price is 38% above last closing price of ₹195. Stock is down 11% over the past year. The company is forecast to post earnings per share of ₹12.40 for next year compared to ₹7.66 last year.
New Risk • Feb 11New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 7.1% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 7.1% per year for the foreseeable future. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results.
Reported Earnings • Feb 07Third quarter 2025 earnings released: EPS: ₹1.52 (vs ₹1.54 in 3Q 2024)Third quarter 2025 results: EPS: ₹1.52 (down from ₹1.54 in 3Q 2024). Revenue: ₹10.5b (up 2.9% from 3Q 2024). Net income: ₹940.2m (down 1.4% from 3Q 2024). Profit margin: 9.0% (down from 9.4% in 3Q 2024). Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.
お知らせ • Jan 30Finolex Industries Limited to Report Q3, 2025 Results on Feb 06, 2025Finolex Industries Limited announced that they will report Q3, 2025 results on Feb 06, 2025
Valuation Update With 7 Day Price Move • Jan 13Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹207, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 8.7% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹116 per share.
お知らせ • Nov 22Finolex Industries Limited Appoints Saurabh Dhanorkar as Managing DirectorFinolex Industries Limited has approved the appointment of Saurabh Dhanorkar as Managing Director for a period of two years with effect from 21st November 2024. Dhanorkar has been associated with the Company since 1983 in various roles and was Managing Director until 2012 when he retired. He is a qualified Chartered Accountant and has contributed significantly to the expansion of the Company from a INR 20 million pipes manufacturing company to a multi-location petrochemicals and plastics processing giant. He retired as Managing Director in 2016 and has been associated with the Company as a Non-Executive Director for the past eight years. Executive Chairman, Prakash Chhabria, emphasized the importance of this leadership change, praising Dhanorkar's vast experience in accounting, finance, commercial, strategy, marketing, and general management. He expressed confidence in Dhanorkar's ability to lead Finolex into its next phase of growth and profitability, citing his client-centric approach, growth mindset, and commitment to the company's values and looks forward to setting new benchmarks under his leadership. The Board at their meeting held on 24th October 2024, considered the recommendation of the Nomination & Remuneration Committee, and approved the appointment of Saurabh Dhanorkar as the Managing Director w.e.f. 21st November 2024, necessary disclosures of which have already been filed with the Stock Exchanges. Ajit Venkataraman will be stepping down as Managing Director at the close of business hours on 20th November 2024.
New Risk • Nov 16New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 0.5% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 0.5% per year for the foreseeable future. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results.
Board Change • Nov 01High number of new directorsThere are 8 new directors who have joined the board in the last 3 years. Independent Director Munesh Khanna was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Oct 26Second quarter 2025 earnings: EPS and revenues miss analyst expectationsSecond quarter 2025 results: EPS: ₹0.66 (down from ₹1.58 in 2Q 2024). Revenue: ₹9.11b (up 3.2% from 2Q 2024). Net income: ₹406.7m (down 59% from 2Q 2024). Profit margin: 4.5% (down from 11% in 2Q 2024). Revenue missed analyst estimates by 10%. Earnings per share (EPS) also missed analyst estimates by 68%. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.
お知らせ • Oct 17Finolex Industries Limited to Report Q2, 2025 Results on Oct 24, 2024Finolex Industries Limited announced that they will report Q2, 2025 results on Oct 24, 2024
Upcoming Dividend • Sep 03Upcoming dividend of ₹2.50 per shareEligible shareholders must have bought the stock before 10 September 2024. Payment date: 03 October 2024. Payout ratio is a comfortable 33% and this is well supported by cash flows. Trailing yield: 0.8%. Lower than top quartile of Indian dividend payers (1.1%). Higher than average of industry peers (0.6%).
お知らせ • Aug 29Finolex Industries Limited, Annual General Meeting, Sep 18, 2024Finolex Industries Limited, Annual General Meeting, Sep 18, 2024, at 16:00 Indian Standard Time.
Price Target Changed • Jul 30Price target increased by 9.4% to ₹310Up from ₹283, the current price target is an average from 16 analysts. New target price is approximately in line with last closing price of ₹322. Stock is up 63% over the past year. The company is forecast to post earnings per share of ₹14.67 for next year compared to ₹7.66 last year.
Reported Earnings • Jul 28First quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFirst quarter 2025 results: EPS: ₹8.10 (up from ₹1.86 in 1Q 2024). Revenue: ₹12.0b (up 1.4% from 1Q 2024). Net income: ₹5.01b (up 334% from 1Q 2024). Profit margin: 42% (up from 9.8% in 1Q 2024). Revenue missed analyst estimates by 14%. Earnings per share (EPS) exceeded analyst estimates. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has increased by 22% per year, which means it is well ahead of earnings.
お知らせ • Jul 21Finolex Industries Limited to Report Q1, 2025 Results on Jul 27, 2024Finolex Industries Limited announced that they will report Q1, 2025 results on Jul 27, 2024
Price Target Changed • May 15Price target increased by 10% to ₹268Up from ₹243, the current price target is an average from 15 analysts. New target price is 12% below last closing price of ₹305. Stock is up 62% over the past year. The company is forecast to post earnings per share of ₹11.74 for next year compared to ₹7.66 last year.
Reported Earnings • May 11Full year 2024 earnings released: EPS: ₹7.66 (vs ₹4.06 in FY 2023)Full year 2024 results: EPS: ₹7.66 (up from ₹4.06 in FY 2023). Revenue: ₹45.0b (up 2.3% from FY 2023). Net income: ₹4.74b (up 89% from FY 2023). Profit margin: 11% (up from 5.7% in FY 2023). The increase in margin was primarily driven by lower expenses. Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has increased by 21% per year, which means it is well ahead of earnings.
お知らせ • May 11+ 1 more updateFinolex Industries Limited Recommends Final Dividend for the Financial Year Ended March 31, 2024Finolex Industries Limited Recommended a final dividend of INR 2.50/- per fully paid-up equity shares of INR 2/- each (face value) i.e. 125% for the financial year ended 31st March, 2024, subject to deduction of tax, as applicable and approval of Members at the ensuing Forty Third Annual General Meeting.
お知らせ • May 05Finolex Industries Limited to Report Q4, 2024 Results on May 10, 2024Finolex Industries Limited announced that they will report Q4, 2024 results on May 10, 2024
お知らせ • Apr 12Finolex Industries Limited Announces the Resignation of Niraj Kedia as Chief Financial Officer, Effective June 30, 2024Finolex Industries Limited announced the resignation of Mr. Niraj Kedia as Chief Financial Officer (CFO) and Key Managerial Personnel, his last date with the Company would be June 30, 2024. Due to personal family commitments.
Valuation Update With 7 Day Price Move • Mar 27Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹249, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 107% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹124 per share.
Price Target Changed • Jan 24Price target increased by 7.9% to ₹243Up from ₹225, the current price target is an average from 14 analysts. New target price is 5.8% above last closing price of ₹230. Stock is up 38% over the past year. The company is forecast to post earnings per share of ₹6.98 for next year compared to ₹4.05 last year.
Reported Earnings • Jan 21Third quarter 2024 earnings released: EPS: ₹1.54 (vs ₹1.28 in 3Q 2023)Third quarter 2024 results: EPS: ₹1.54 (up from ₹1.28 in 3Q 2023). Revenue: ₹10.2b (down 9.3% from 3Q 2023). Net income: ₹954.0m (up 20% from 3Q 2023). Profit margin: 9.4% (up from 7.1% in 3Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 24% per year, which means it is well ahead of earnings.
お知らせ • Jan 19Finolex Industries Limited Designates Swad Deshpande, Head - Purchase as Senior Management PersonnelThe Board of Directors of Finolex Industries Limited at its meeting held on 18th January, 2024, the Board of Directors has designated Mr. Swad Deshpande, Head - Purchase as Senior Management Personnel of the Company with effect from 18th January, 2024. He comes with 30+ years of experience with various large MNCs and Indian Companies including Greaves Electric Mobility Limited, Tata Motors Ltd., Samsung India Electronics Private Limited and Philips Electronics India Limited.
お知らせ • Jan 11Finolex Industries Limited to Report Q3, 2024 Results on Jan 18, 2024Finolex Industries Limited announced that they will report Q3, 2024 results on Jan 18, 2024
Reported Earnings • Oct 22Second quarter 2024 earnings released: EPS: ₹1.58 (vs ₹1.54 loss in 2Q 2023)Second quarter 2024 results: EPS: ₹1.58 (up from ₹1.54 loss in 2Q 2023). Revenue: ₹9.45b (flat on 2Q 2023). Net income: ₹979.6m (up ₹1.93b from 2Q 2023). Profit margin: 10% (up from net loss in 2Q 2023). Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 29% per year, which means it is well ahead of earnings.
お知らせ • Oct 14Finolex Industries Limited to Report Q2, 2024 Results on Oct 21, 2023Finolex Industries Limited announced that they will report Q2, 2024 results at 4:00 PM, Indian Standard Time on Oct 21, 2023
お知らせ • Aug 31Finolex Industries Limited Approves Dividend for the Financial Year Ended March 31, 2023Finolex Industries Limited approved dividend of 1.50 per equity share for the financial year ended March 31, 2023 at its AGM held on August 28, 2023.
Upcoming Dividend • Aug 14Upcoming dividend of ₹1.50 per share at 0.7% yieldEligible shareholders must have bought the stock before 21 August 2023. Payment date: 11 September 2023. Payout ratio is a comfortable 37% but the company is paying out more than the cash it is generating. Trailing yield: 0.7%. Lower than top quartile of Indian dividend payers (1.4%). Lower than average of industry peers (0.9%).
お知らせ • Aug 06Finolex Industries Limited, Annual General Meeting, Aug 28, 2023Finolex Industries Limited, Annual General Meeting, Aug 28, 2023, at 16:00 Indian Standard Time. Agenda: To receive, consider, approve and adopt the audited Standalone Financial Statements of the Company for the financial year ended March 31, 2023 and the Reports of the Board of Directors and the Auditors thereon; to receive, consider, approve and adopt the audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2023 and the Report of the Auditors thereon; to declare a final dividend; to appoint a Director in place of Mr. Saurabh S. Dhanorkar who retires by rotation, and being eligible, offers himself for e-appointment and to consider other matters.
Reported Earnings • Jul 20First quarter 2024 earnings released: EPS: ₹1.86 (vs ₹1.60 in 1Q 2023)First quarter 2024 results: EPS: ₹1.86 (up from ₹1.60 in 1Q 2023). Revenue: ₹12.2b (up 2.5% from 1Q 2023). Net income: ₹1.15b (up 16% from 1Q 2023). Profit margin: 9.5% (up from 8.3% in 1Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 10.0% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 26% per year, which means it is well ahead of earnings.
お知らせ • Jul 13Finolex Industries Limited to Report Q1, 2024 Results on Jul 19, 2023Finolex Industries Limited announced that they will report Q1, 2024 results on Jul 19, 2023
Board Change • Jun 05Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 6 experienced directors. 2 highly experienced directors. Director of Technical & Additional Whole-Time Director Saumya Chakraborty was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Jun 01Finolex Industries Limited Announces Cessation of Ajit Venkataraman as Chief Executive OfficerFinolex Industries Limited announced that In term of subject referred matter and in continuation to previous communication dated 22nd May, 2023, this is to inform that: Consequent to appointment of Mr. Ajit Venkataraman as Managing Director of the Company from 1st June, 2023, he ceased as Chief Executive Officer of the Company from the close of business hours of 31st May, 2023.
Price Target Changed • May 30Price target increased by 8.3% to ₹209Up from ₹193, the current price target is an average from 12 analysts. New target price is 20% above last closing price of ₹175. Stock is up 11% over the past year. The company is forecast to post earnings per share of ₹8.87 for next year compared to ₹4.04 last year.
お知らせ • May 23+ 1 more updateFinolex Industries Limited Recommends Final Dividend for the Financial Year Ended March 31, 2023Finolex Industries Limited at its board meeting held on May 22, 2023 recommended a final dividend of INR 1.50 per fully paid-up equity shares of INR 2 each (face value) i.e. 75% for the financial year ended 31st March, 2023, subject to deduction of tax, as applicable and approval of Members at the upcoming forty-second Annual General Meeting.
Reported Earnings • May 23Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: EPS: ₹4.04 (down from ₹16.94 in FY 2022). Revenue: ₹45.2b (down 2.8% from FY 2022). Net income: ₹2.51b (down 76% from FY 2022). Profit margin: 5.5% (down from 23% in FY 2022). The decrease in margin was primarily driven by higher expenses. Revenue missed analyst estimates by 2.1%. Earnings per share (EPS) also missed analyst estimates by 5.4%. Revenue is forecast to grow 9.1% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 31% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • May 17Finolex Industries Limited to Report Q4, 2023 Results on May 22, 2023Finolex Industries Limited announced that they will report Q4, 2023 results on May 22, 2023
Reported Earnings • Feb 08Third quarter 2023 earnings released: EPS: ₹1.28 (vs ₹2.86 in 3Q 2022)Third quarter 2023 results: EPS: ₹1.28 (down from ₹2.86 in 3Q 2022). Revenue: ₹12.2b (up 21% from 3Q 2022). Net income: ₹795.4m (down 55% from 3Q 2022). Profit margin: 6.5% (down from 18% in 3Q 2022). Revenue is expected to decline by 2.6% p.a. on average during the next 3 years, while revenues in the Chemicals industry in India are expected to grow by 12%. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.
お知らせ • Jan 28Finolex Industries Limited to Report Q3, 2023 Results on Feb 04, 2023Finolex Industries Limited announced that they will report Q3, 2023 results on Feb 04, 2023
Valuation Update With 7 Day Price Move • Nov 07Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹157, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 41% over the past three years.
Board Change • Oct 31High number of new directorsDirector of Technical & Additional Whole-Time Director Saumya Chakraborty was the last director to join the board, commencing their role in 2022.
Major Estimate Revision • Oct 28Consensus forecasts updatedThe consensus outlook for 2023 has been updated. 2023 revenue forecast increased from ₹40.9b to ₹41.6b. EPS estimate fell from ₹7.00 to ₹3.90 per share. Net income forecast to shrink 44% next year vs 22% growth forecast for Chemicals industry in India . Consensus price target down from ₹174 to ₹168. Share price fell 3.8% to ₹133 over the past week.
Reported Earnings • Oct 23Second quarter 2023 earnings released: ₹1.54 loss per share (vs ₹3.76 profit in 2Q 2022)Second quarter 2023 results: ₹1.54 loss per share (down from ₹3.76 profit in 2Q 2022). Revenue: ₹9.80b (down 9.5% from 2Q 2022). Net loss: ₹953.8m (down 141% from profit in 2Q 2022). Revenue is forecast to grow 1.6% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
お知らせ • Oct 15Finolex Industries Limited to Report Q2, 2023 Results on Oct 21, 2022Finolex Industries Limited announced that they will report Q2, 2023 results on Oct 21, 2022
Major Estimate Revision • Sep 06Consensus forecasts updatedThe consensus outlook for 2023 has been updated. 2023 revenue forecast increased from ₹39.6b to ₹40.9b. EPS estimate fell from ₹7.80 to ₹7.00 per share. Net income forecast to shrink 45% next year vs 22% growth forecast for Chemicals industry in India . Consensus price target broadly unchanged at ₹177. Share price was steady at ₹153 over the past week.
お知らせ • Sep 01+ 1 more updateFinolex Industries Limited Approves Special Dividend for the Financial Year Ended March 31, 2022Finolex Industries Limited approved the declaration of a special dividend of INR 2 per equity share for the financial year ended March 31, 2022, at its forty-first annual general meeting held on August 30, 2022.
Upcoming Dividend • Aug 15Upcoming dividend of ₹4.00 per shareEligible shareholders must have bought the stock before 22 August 2022. Payment date: 29 September 2022. Payout ratio is a comfortable 12% and this is well supported by cash flows. Trailing yield: 2.8%. Within top quartile of Indian dividend payers (1.7%). Higher than average of industry peers (0.7%).
お知らせ • Aug 07Finolex Industries Limited, Annual General Meeting, Aug 30, 2022Finolex Industries Limited, Annual General Meeting, Aug 30, 2022, at 16:00 Indian Standard Time. Agenda: To consider the audited standalone financial statements of the Company for the financial year ended March 31, 2022, together with the Reports of the Board of Directors and the Auditors thereon; to declare final dividend of 2 per equity share and special dividend of 2 per equity share for the financial year ended March 31, 2022; to appoint a Director in place of Mrs. Ritu P. Chhabria(DIN: 00062144) who retires by rotation, and being eligible, offers herself for re-appointment; and to consider other matters.
Major Estimate Revision • Jul 29Consensus revenue estimates fall by 15%The consensus outlook for revenues in 2023 has deteriorated. 2023 revenue forecast decreased from ₹46.1b to ₹39.1b. EPS estimate fell from ₹9.50 to ₹7.00 per share. Net income forecast to shrink 42% next year vs 24% growth forecast for Chemicals industry in India . Consensus price target down from ₹204 to ₹183. Share price fell 5.1% to ₹133 over the past week.
Price Target Changed • Jul 26Price target decreased to ₹188Down from ₹204, the current price target is an average from 7 analysts. New target price is 43% above last closing price of ₹131. Stock is down 25% over the past year. The company is forecast to post earnings per share of ₹7.00 for next year compared to ₹16.94 last year.
お知らせ • Jul 25+ 1 more updateFinolex Industries Limited Recommends Special Dividend for the Year Ended 31 March 2022Finolex Industries Limited at the Board of Directors meeting held on 18th May, 2022 recommended a special dividend of INR 2 (100%) per equity share of the face value of INR 2 each, for the financial year ended 31st March 2022. The said dividend, as recommended by the Board, if declared at the upcoming 41st Annual General Meeting, will be paid within 30 days of the date of its declaration to eligible Shareholders holding shares as on record datewhich will be communicated separately.
お知らせ • Jul 23Finolex Industries Limited Appoints Ajit Venkataraman as Chief Executive Officer, Effective August 1, 2022Finolex Industries Limited at its board meeting held on July 22, 2022, approved appointment of Ajit Venkataraman as Chief Executive Officer and Key Managerial Personnel of the Company with effect from August 1, 2022. Ajit Venkataraman is an MBA from University of Michigan and brings in 27 years of rich experience across US, India & South East Asia. Ajit Venkataraman comes with diverse industry experience both national and global, and an impressive track record of delivering performance consistently through the years. He has been instrumental in running multicultural organization m Automobile and Logistics industry. His strength lies in strategic planning, managing JVs, new market entry, business turnaround, product development and management. He was previously associated with Tecumseh, Kearney, Tata Motors & APM Terminals Inland Services Asia and Greaves Cotton Limited.
Reported Earnings • Jul 23First quarter 2023 earnings released: EPS: ₹1.60 (vs ₹2.35 in 1Q 2022)First quarter 2023 results: EPS: ₹1.60 (down from ₹2.35 in 1Q 2022). Revenue: ₹12.1b (up 26% from 1Q 2022). Net income: ₹992.2m (down 32% from 1Q 2022). Profit margin: 8.2% (down from 15% in 1Q 2022). Over the next year, revenue is expected to shrink by 7.2% compared to a 17% growth forecast for the industry in India. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
Price Target Changed • Jul 22Price target decreased to ₹200Down from ₹216, the current price target is an average from 7 analysts. New target price is 43% above last closing price of ₹140. Stock is down 21% over the past year. The company is forecast to post earnings per share of ₹9.50 for next year compared to ₹16.94 last year.
お知らせ • Jul 14Finolex Industries Limited to Report Q1, 2023 Results on Jul 22, 2022Finolex Industries Limited announced that they will report Q1, 2023 results at 3:30 PM, Indian Standard Time on Jul 22, 2022
お知らせ • Jun 03Sanjay S. Math Ceases to Be Director of Finolex Industries LimitedFinolex Industries Limited informed that Mr. Sanjay S. Math has ceased to be Director and Key Managerial Personnel (KMP) of the Company with effect from closing of business hours of 31 May, 2022 .
Reported Earnings • May 20Full year 2022 earnings: EPS and revenues exceed analyst expectationsFull year 2022 results: EPS: ₹16.94 (up from ₹11.89 in FY 2021). Revenue: ₹46.5b (up 34% from FY 2021). Net income: ₹10.5b (up 43% from FY 2021). Profit margin: 23% (up from 21% in FY 2021). Revenue exceeded analyst estimates by 9.0%. Earnings per share (EPS) also surpassed analyst estimates by 45%. Over the next year, revenue is forecast to grow 4.5%, compared to a 21% growth forecast for the industry in India. Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth.
お知らせ • May 19+ 3 more updatesFinolex Industries Limited Announces Retirement of Sanjay S. Math, Managing DirectorFinolex Industries Limited at its board meeting held on May 18, 2022, approved Retirement of Mr. Sanjay S. Math, Managing Director with effective May 31, 2022.
Board Change • Apr 27High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director of Finance & Additional Whole-time Director Anil Whabi was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Jan 26Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindThird quarter 2022 results: EPS: ₹2.86 (down from ₹4.18 in 3Q 2021). Revenue: ₹10.2b (down 4.0% from 3Q 2021). Net income: ₹1.77b (down 32% from 3Q 2021). Profit margin: 17% (down from 24% in 3Q 2021). The decrease in margin was primarily driven by higher expenses. Revenue missed analyst estimates by 34%. Earnings per share (EPS) exceeded analyst estimates by 30%. Over the next year, revenue is forecast to stay flat compared to a 19% growth forecast for the industry in India. Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth.
Price Target Changed • Nov 02Price target increased to ₹220Up from ₹201, the current price target is an average from 5 analysts. New target price is approximately in line with last closing price of ₹228. Stock is up 106% over the past year. The company is forecast to post earnings per share of ₹11.57 for next year compared to ₹11.89 last year.
Reported Earnings • Nov 01Second quarter 2022 earnings released: EPS ₹3.76 (vs ₹1.98 in 2Q 2021)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2022 results: Revenue: ₹11.1b (up 90% from 2Q 2021). Net income: ₹2.33b (up 90% from 2Q 2021). Profit margin: 21% (in line with 2Q 2021).
Valuation Update With 7 Day Price Move • Oct 04Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹225, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 33x in the Chemicals industry in India. Total returns to shareholders of 134% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹156 per share.
お知らせ • Sep 24Finolex Industries Limited Approves Special Dividend for the Financial Year Ended 31 March, 2021Finolex Industries Limited at its annual general meeting of the Members of the Company was held on 22nd September, 2021, approved to declare a special dividend of INR 2 per equity share for the financial year ended 31 March, 2021.
Price Target Changed • Sep 01Price target increased to ₹196Up from ₹180, the current price target is an average from 6 analysts. New target price is 17% above last closing price of ₹168. Stock is up 66% over the past year.
Reported Earnings • Aug 02First quarter 2022 earnings released: EPS ₹2.35 (vs ₹0.91 in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹9.81b (up 75% from 1Q 2021). Net income: ₹1.46b (up 157% from 1Q 2021). Profit margin: 15% (up from 10% in 1Q 2021). The increase in margin was driven by higher revenue.
Major Estimate Revision • Jul 03Consensus EPS estimates increase to ₹8.52The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from ₹35.5b to ₹38.7b. EPS estimate increased from ₹7.69 to ₹8.52 per share. Net income forecast to shrink 28% next year vs 18% growth forecast for Chemicals industry in India . Consensus price target up from ₹150 to ₹178. Share price rose 5.8% to ₹184 over the past week.